The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: A meta-analysis

Journal of the American Dental Association

Volumn 143, Issue 9, 2012, Pages e46-e56

  Li, Wenyang ^a,b   Xiao, Lin ^a,b   Hu, Jing ^a,b  

^a Sichuan University ^*

^b SICHUAN UNIVERSITY   (China)

Author keywords

AB: Autogenous bone; BDX: Bovine derived xenograft; BG: Bioactive glass; bone grafts; BPBM: Bovine porous bone mineral; CAL: Clinical attachment level; DFDBA: Demineralized freeze dried bone allograft; EMD: Enamel matrix derivative; EMP: Enamel matrix proteins; Enamel matrix derivative; GTR: Guided tissue regeneration; intrabony defects; meta analysis; PPD: Probing pocket depth; randomized controlled trials; RCT: Randomized controlled trial; REC: Gingival recession; TCP: Tricalcium phosphate

Indexed keywords

ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN;

ALVEOLAR BONE LOSS; BONE TRANSPLANTATION; COMPARATIVE STUDY; FOLLOW UP; GINGIVA DISEASE; HUMAN; META ANALYSIS; METHODOLOGY; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL FLAPS; TREATMENT OUTCOME;

ALVEOLAR BONE LOSS; BONE TRANSPLANTATION; DENTAL ENAMEL PROTEINS; FOLLOW-UP STUDIES; GINGIVAL RECESSION; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL FLAPS; TREATMENT OUTCOME;

EID: 84887264224     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2012.0327     Document Type: Article

References (24)

1. Caton, JG, Greenstein, G, Factors related to periodontal regeneration. Periodontol 2000 1:1 (1993), 9–15.
2. Cortellini, P, Pini Prato, G, Tonetti, MS, Periodontal regeneration of human infrabony defects, II: re-entry procedures and bone measures. J Periodontol 64:4 (1993), 261–268.
3. Cortellini, P, Tonetti, MS, Focus on intrabony defects: guided tissue regeneration. Periodontol 2000 22 (2000), 104–132.
4. Heijl, L, Heden, G, Svärdstrom, G, Ostgren, A, Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:9 pt 2 (1997), 705–714.
5. Tonetti, MS, Fourmousis, I, Suvan, J, Cortellini, P, Bragger, U, Lang, NP, European Research Group on Periodontology, Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. J Clin Periodontol 31:12 (2004), 1092–1098.
6. Esposito, M, Coulthard, P, Worthington, HV, Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev(2), 2003, CD003875.
7. Mellonig, JT, Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int J Periodontics Restorative Dent 19:1 (1999), 8–19.
8. Yukna, RA, Krauser, JT, Callan, DP, Evans, GH, Cruz, R, Martin, M, Multicenter clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results. J Periodontol 71:11 (2000), 1671–1679.
9. Lekovic, V, Camargo, PM, Weinlaender, M, Nedic, M, Aleksic, Z, Kenney, EB, A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 71:7 (2000), 1110–1116.
10. Zucchelli, G, Amore, C, Montebugnoli, L, De Sanctis, M, Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74:12 (2003), 1725–1735.
11. Guida, L, Annunziata, M, Belardo, S, Farina, R, Scabbia, A, Trombelli, L, Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 78:2 (2007), 231–238.
12. Lyngstadaas, SP, Lundberg, E, Ekdahl, H, Andersson, C, Gestrelius, S, Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 28:2 (2001), 181–188.
13. Gestrelius, S, Andersson, C, Lidström, D, Hammarstrom, L, Somerman, M, In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 24:9 pt 2 (1997), 685–692.
14. Camargo, PM, Lekovic, V, Weinlaender, M, Vasilic, N, Kenney, EB, Madzarevic, M, The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intra-bony defects in humans. J Clin Periodontol 28:11 (2001), 1016–1022.
15. Velasquez-Plata, D, Scheyer, ET, Mellonig, JT, Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans (published correction appears in J Periodontol 2002;73[6]:684). J Periodontol 73:4 (2002), 433–440.
16. Gurinsky, BS, Mills, MP, Mellonig, JT, Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 75:10 (2004), 1309–1318.
17. Sculean, A, Pietruska, M, Schwarz, F, Willershausen, B, Arweiler, NB, Auschill, TM, Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass: a controlled clinical study. J Clin Periodontol 32:1 (2005), 111–117.
18. Bokan, I, Bill, JS, Schlagenhauf, U, Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects. J Clin Periodontol 33:12 (2006), 885–893.
19. Kuru, B, Yilmaz, S, Argin, K, Noyan, Ü Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects (published online ahead of print May 16, 2006). Clin Oral Investig 10:3 (2006), 227–234 10.1007/s00784-006-0052-5.
20. Jepsen, S, Topoll, H, Rengers, H, et al. Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial (published online ahead of print March 12, 2008). J Clin Periodontol 35:5 (2008), 420–428 10.1111/j.1600-051X.2008.01217.x.
21. Yilmaz, S, Cakar, G, Yildirim, B, Sculean, A, Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. J Clin Periodontol 37:6 (2010), 544–550.
22. Cortellini, P, Tonetti, MS, Clinical and radiographic outcomes of the modified minimally invasive surgical technique with and without regenerative materials: a randomized-controlled trial in intra-bony defects (published online ahead of print Feb. 8, 2011). J Clin Periodontol 38:4 (2011), 365–373 10.1111/j.1600-051X.2011. 01705.x.
23. Sculean, A, Pietruska, M, Arweiler, NB, Auschill, TM, Nemcovsky, C, Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass (published online ahead of print April 23, 2007). J Clin Periodontol 34:6 (2007), 507–513 10.1111/1600-051X.2007.01084.x.
24. Tu, YK, Woolston, A, Faggion, CM Jr, Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials (published online ahead of print Dec. 1, 2009). J Clin Periodontol 37:1 (2010), 59–79 10.1111/j.1600-051X.2009.01499.x.